Clinical outcomes and their correlation with gene expression in patients with advanced gastric cancer treated with pembrolizumab
New data on @Merck’s pembrolizumab shows how gene-expression info might predict patient response to the drug.
New Agents Show Promise in Gastric Cancer
In a talk at the 2015 World Congress on GI Cancer, Josep Tabernero, MD, PhD, provided a summary of novel agents that... Read More
Researchers develop new breath test to diagnose oesophageal and gastric cancer
Researchers have devised a breath test that can help doctors diagnose the early signs of oesophageal and gastric cancer in minutes.
Helicobacter pylori causes gene activity in the gastric cells resembling the activity of cancer cells
Around half of the global population is chronically infected with the stomach bacterium Helicobacter pylori, almost 1% of whom go on to... Read More
Pembrolizumab Active in Advanced Gastric Cancer
The anti–PD-1 monoclonal antibody, pembrolizumab (MK-3475), demonstrated promising antitumor activity in advanced gastric cancer, results from the KEYNOTE-012 study presented at the... Read More
New drug combination boosts survival in advanced stomach and esophageal cancers
Patients whose metastatic stomach or esophageal cancers were driven by a mutatedHER2 gene had markedly improved response rates and survival when bevacizumab... Read More
Breath test ‘could give clues to stomach cancer risk’
A simple breath test could help predict whether people with gut problems are at high risk of developing stomach cancer, an early... Read More
Parsing The Latest Evidence That Aspirin And Coffee Keep Cancer Away
Anyone looking for an excuse to get through the morning staff meeting by popping an aspirin and downing a lot of coffee... Read More
Scientists have found that most gastric tumors harbor genetic alterations that may respond to targeted therapies
Background. Gastric cancer (GC) is a major global cancer burden and the second most common cause of global cancer-related deaths. The addition... Read More
Oncolytics Biotech is seeking orphan-drug status for a virus-based treatment for gastric cancer
Brad Thompson, CEO of Oncolytics Biotech, was thrilled to see CBS’ 60 Minutes bring attention to virus-based cancer treatments a couple weeks... Read More
